Defiance Daily Target 2X Long LLY ETF (LLYX)

Assets	$76.12M
Expense Ratio	1.32%
PE Ratio	n/a
Shares Out	5.63M
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
Payout Frequency	n/a
Payout Ratio	n/a

Volume	1,027,294
Open	13.97
Previous Close	13.93
Day's Range	13.92 - 14.39
52-Week Low	9.60
52-Week High	28.50
Beta	n/a
Holdings	9
Inception Date	Aug 7, 2024

About LLYX

Fund Home Page

The Defiance Daily Target 2X Long LLY ETF (LLYX) is an exchange-traded fund that mostly invests in health care equity. The fund seeks to provide 2x leveraged exposure to the daily share price movement of the Eli Lilly and Company (NYSE: LLY), less fees and expenses. LLYX was launched on Aug 7, 2024 and is issued by Defiance.

• Asset Class: Equity
• Stock Exchange: NYSEARCA
• Ticker Symbol: LLYX
• ETF Provider: Defiance

Performance

LLYX had a total return of -50.04% in the past year, including dividends. Since the fund's inception, the average annual return has been -37.93%.